GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (FRA:5GV) » Definitions » Cyclically Adjusted PB Ratio

Genovis AB (FRA:5GV) Cyclically Adjusted PB Ratio : 17.21 (As of Apr. 29, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Genovis AB Cyclically Adjusted PB Ratio?

As of today (2025-04-29), Genovis AB's current share price is €2.065. Genovis AB's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was €0.12. Genovis AB's Cyclically Adjusted PB Ratio for today is 17.21.

The historical rank and industry rank for Genovis AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:5GV' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.78   Med: 35.67   Max: 104.49
Current: 16.74

During the past years, Genovis AB's highest Cyclically Adjusted PB Ratio was 104.49. The lowest was 2.78. And the median was 35.67.

FRA:5GV's Cyclically Adjusted PB Ratio is ranked worse than
94.6% of 667 companies
in the Biotechnology industry
Industry Median: 1.44 vs FRA:5GV: 16.74

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Genovis AB's adjusted book value per share data for the three months ended in Dec. 2024 was €0.303. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.12 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Genovis AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Genovis AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genovis AB Cyclically Adjusted PB Ratio Chart

Genovis AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.74 92.46 48.55 44.79 17.67

Genovis AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.79 27.66 22.54 20.61 17.67

Competitive Comparison of Genovis AB's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Genovis AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genovis AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genovis AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Genovis AB's Cyclically Adjusted PB Ratio falls into.


;
;

Genovis AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Genovis AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.065/0.12
=17.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genovis AB's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Genovis AB's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.303/132.9872*132.9872
=0.303

Current CPI (Dec. 2024) = 132.9872.

Genovis AB Quarterly Data

Book Value per Share CPI Adj_Book
201503 0.033 99.950 0.044
201506 0.052 99.995 0.069
201509 0.033 100.228 0.044
201512 0.024 100.276 0.032
201603 0.015 100.751 0.020
201606 0.037 101.019 0.049
201609 0.034 101.138 0.045
201612 0.029 102.022 0.038
201703 0.024 102.022 0.031
201706 0.036 102.752 0.047
201709 0.034 103.279 0.044
201712 0.030 103.793 0.038
201803 0.027 103.962 0.035
201806 0.038 104.875 0.048
201809 0.038 105.679 0.048
201812 0.040 105.912 0.050
201903 0.042 105.886 0.053
201906 0.043 106.742 0.054
201909 0.054 107.214 0.067
201912 0.054 107.766 0.067
202003 0.117 106.563 0.146
202006 0.117 107.498 0.145
202009 0.118 107.635 0.146
202012 0.131 108.296 0.161
202103 0.133 108.360 0.163
202106 0.136 108.928 0.166
202109 0.136 110.338 0.164
202112 0.170 112.486 0.201
202203 0.184 114.825 0.213
202206 0.184 118.384 0.207
202209 0.188 122.296 0.204
202212 0.175 126.365 0.184
202303 0.232 127.042 0.243
202306 0.245 129.407 0.252
202309 0.246 130.224 0.251
202312 0.261 131.912 0.263
202403 0.277 132.205 0.279
202406 0.281 132.716 0.282
202409 0.299 132.304 0.301
202412 0.303 132.987 0.303

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Genovis AB  (FRA:5GV) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Genovis AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Genovis AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Genovis AB Business Description

Industry
Traded in Other Exchanges
Address
Scheelevagen 2, Box 790, Lund, SWE, SE-220 07
Genovis AB provides enzymes and technologies for the analytical characterization and conjugation of biopharmaceuticals. The principal activities of the company are to develop, produce, and market tools for developing new drugs and diagnostics. Its product line comprises GingisREX, FabRICATOR, GlyCLICK, GingisKHAN, GlycINATOR, Fabulous, lgGZERO, and Enzymes for O-glycan. The company's main product category consists of Enzymes and Antibodies. Geographically its segments include Sweden and the rest of the world.

Genovis AB Headlines

No Headlines